138 evolution-"https:"-"https:"-"https:"-"https:"-"https:"-"FCiências" positions at NIST
Sort by
Refine Your Search
-
technology development community and cell line repositories to design reference transcriptome samples, and then develop methods to integrate transcriptome sequencing data from short and long read technologies
-
@nist.gov 301.975.6740 Description With the development of nanoparticle and colloidal technologies that include processing in the dispersed phase (or are fundamentally liquid phase processes), there is a need
-
) are beginning to broadly impact physics: from probing the evolution of galaxies to calculating quantum wave functions to discovering new states of matter. This postdoctoral research opportunity centers
-
/hospitals/factories, elder care, and the Internet of Things (IoT). NIST extensive research activities in this area include development of new solutions as well as rigorous testing of indoor localization and
-
@nist.gov 301 975 2093 Description This opportunity focuses on the development of analytical methods and/or data processing techniques that could be used to advance drug detection and identification (or drug
-
), in the CODATA evaluation of fundamental constants, and in more stringent tests of quantum electrodynamics (QED). Experimental efforts include the development of novel ion trap architectures
-
and then accessed by a team of experts. We are seeking candidates to address these challenges that range from algorithm development, simulation of reference data, algorithmic accuracy evaluations, design of
-
to profile the microbial communities based on metagenomics and transcriptomics approaches. The comprehensive profiling methodologies will provide the foundation for the development of reference materials
-
properties. While our focus is on industrially important fluids, such as fuels and refrigerants, we also welcome proposals that would yield data primarily intended for model development, such as studies
-
NIST only participates in the February and August reviews. The development of therapies and other products based on pluripotent stem cells requires control of the pluripotent and differentiated